Evidence map›Paper›PMID 19571015›Full record

ArticleJournal of clinical microbiology2009

Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed.

Sylvia Cardoso Leao, Enrico Tortoli, Cristina Viana-Niero, Suely Yoko Mizuka Ueki, Karla Valeria Batista Lima, Maria Luiza Lopes, Jesus Yubero, Maria Carmen Menendez, Maria Jesus Garcia

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 138 citations in OpenAlex.

  1. Genomic-enabled classification of threeJournal of clinical microbiology · 2025
    Article
  2. Article
  3. Article
  4. Molecular Identification of Strains within thePolish journal of microbiology · 2023
    Article
  5. Short SignatureMicrobiology spectrum · 2022
    Article
  6. Article
  7. The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  8. Article
  9. Article
  10. PCR amplification of theExperimental and therapeutic medicine · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Article
  17. Characterization ofFrontiers in microbiology · 2017
    Article
  18. Rapidly Growing Mycobacteria.Microbiology spectrum · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Sylvia Cardoso LeaoDepartamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de Sao Paulo, Sao Paulo, SP 04023-062, Brazil. sylvia.leao@unifesp.br
Enrico Tortoli
Cristina Viana-Niero
Suely Yoko Mizuka Ueki
Karla Valeria Batista Lima
Maria Luiza Lopes
Jesus Yubero
Maria Carmen Menendez
Maria Jesus Garcia
Universidad Autónoma de Madrid · ESInstituto Evandro Chagas · BRUniversidade Federal de São Paulo · BRInstituto Adolfo Lutz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An outbreak of postsurgical infections caused by rapidly growing mycobacteria has been ongoing in Brazil since 2004. The degrees of similarity of the rpoB and hsp65 sequences from the clinical isolates and the corresponding sequences from both the Mycobacterium massiliense and the M. bolletii type strains were above the accepted limit for interspecies variability, leading to conflicting identification results. Therefore, an extensive characterization of members of the M. chelonae-M. abscessus group was carried out. The M. abscessus, M. chelonae, M. immunogenum, M. massiliense, and M. bolletii type strains and a subset of clinical isolates were analyzed by biochemical tests, high-performance liquid chromatography, drug susceptibility testing, PCR-restriction enzyme analysis of hsp65 (PRA-hsp65), rpoB, and hsp65 gene sequencing and analysis of phylogenetic trees, DNA-DNA hybridization (DDH), and restriction fragment length polymorphism (RFLP) analysis of the 16S rRNA gene (RFLP-16S rRNA). The clinical isolates and the M. abscessus, M. massiliense, and M. bolletii type strains could not be separated by phenotypic tests and were grouped in the phylogenetic trees obtained. The results of DDH also confirmed the >70% relatedness of the clinical isolates and the M. abscessus, M. massiliense, and M. bolletii type strains; and indistinguishable RFLP-16S rRNA patterns were obtained. On the contrary, the separation of clinical isolates and the M. abscessus, M. massiliense, and M. bolletii type strains from M. chelonae and M. immunogenum was supported by the results of PRA-hsp65, DDH, and RFLP-16S rRNA and by the rpoB and hsp65 phylogenetic trees. Taken together, these results led to the proposition that M. abscessus, M. massiliense, and M. bolletii represent a single species, that of M. abscessus. Two subspecies are also proposed, M. abscessus subsp. abscessus and M. abscessus subsp. massiliense, and these two subspecies can be distinguished by two different PRA-hsp65 patterns, which differ by a single HaeIII band, and by differences in their rpoB (3.4%) and hsp65 (1.3%) sequences.

Indexed as

Disease OutbreaksBacterial ProteinsBacterial Typing TechniquesBrazilChromatography, High Pressure LiquidCluster AnalysisDNA, BacterialDNA, RibosomalGenotypeHumansMicrobial Sensitivity TestsMycobacteriumMycobacterium chelonaeMycobacterium Infections, NontuberculousMycolic AcidsPhylogenyBacterial ProteinsDNA, BacterialDNA, RibosomalMycolic AcidsRNA, Ribosomal, 16S

Identifiers

PMID19571015
PMCPMC2738059
OpenAlexW2103014188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.